华北制药：注射用盐酸万古霉素获药品注册证书

Core Viewpoint - North China Pharmaceutical (600812) has received approval from the National Medical Products Administration for the injection of Vancomycin Hydrochloride (0.5g), indicating successful completion of the consistency evaluation of quality and efficacy for generic drugs [1] Company Summary - The approved Vancomycin Hydrochloride is primarily used to inhibit bacterial cell wall biosynthesis, demonstrating bactericidal activity [1] - Vancomycin also alters the permeability of bacterial cell membranes and RNA synthesis, making it effective against infections caused by Methicillin-resistant Staphylococcus aureus and other bacteria [1]